GROWTH EQUITY OPPORTUNITIES FUND IV, LLC

TIMONIUM, MD How do I update this listing?

Growth Equity Opportunities Fund IV is based out of Timonium. Whalewisdom has at least 22 13D filings, and 15 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Create Alert
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
Verona Pharma PLC ADR (VRNA) HEALTH CARE 42,638,131 298,466,917.00 1 13D 2020-07-22
Addex Therapeutics Ltd ADS (ADXN) HEALTH CARE 7,704,600 81,283,530.00 2 13D 2021-01-11
AVEO Pharmaceuticals Inc (AVEO) HEALTH CARE 5,424,009 31,296,531.93 3 13D 2020-06-19
Strongbridge Biopharma plc (SBBP) HEALTH CARE 2,141,308 12,847,848.00 4 13D 2015-10-21
Achaogen Inc (AKAOQ) HEALTH CARE 6,393,910 63,939.10 5 13D 2016-12-19

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

**EXPERIMENTAL** Current UK Positions

Updated daily

Contains transactions from January 1st, 2015 on.

Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights
GROWTH EQUITY OPPORTUNITIES FUND IV, LLC Verona Pharma plc 2020-07-22 40,868,504 9.86%

Position History

Holder Issuer Transaction Date Number of Voting Rights % of Voting Rights

Elevate your investments